Esperion Therapeutics
ESPR
#6663
Rank
HK$6.42 B
Marketcap
HK$24.94
Share price
0.00%
Change (1 day)
31.96%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -HK$22.10

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$0.16. In 2022 the company made an earnings per share (EPS) of -HK$27.84 an increase over its 2021 EPS that were of -HK$74.97.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$22.10-20.6%
2022-HK$27.84-62.87%
2021-HK$74.9780.38%
2020-HK$41.5650.14%
2019-HK$27.68-53.18%
2018-HK$59.137.41%
2017-HK$55.05110.81%
2016-HK$26.1147.35%
2015-HK$17.720.89%
2014-HK$17.5728.84%
2013-HK$13.63-89.3%
2012-HK$127.44
2002-HK$53.698.89%
2001-HK$49.30-83.77%
2000-HK$303.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.96-3,900.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$328.64-209,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-HK$45.80 29,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-HK$1.18 650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-HK$0.86 450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$2.98-2,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA